glp-1 schedule A timeline of GLP- 1 discovery and clinical development. Created in GLP-1 analog dosing chart

Bydureon Inches Closer to Possible Approval For type 2 patients, the use of GLP-1 agonists (such as Victoza and Byetta) can often lead to significant improvements in blood glucose control and weight loss with little risk for hypoglycemia

Nonalcoholic fatty liver disease, especially nonalcoholic steatohepatitis, has a higher liver-related and overall mortality risk than the general population [1, 3]

Tesamorelin is the clinically validated choice for visceral abdominal fat reduction

Table 6 Clinical data of RAS blockers

Many patients have managed symptoms by keeping a food journal and monitoring their diet, especially the practice of avoiding processed foods, including fermented foods, and increasing omega-3 fatty acids